Cite
Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU)
MLA
Rey, Ib, et al. Safety of Inflammatory Bowel Disease Treatments in Patients with Solid Organ Transplantation (EITOS Study of GETECCU). Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..2c5a86f812716796b49fb944f55a1af0&authtype=sso&custid=ns315887.
APA
Rey, I., Suarez, C., Luque, A., Caballol, B., Soutullo, C., Bravo, A., Castano, A., Gros, B., Hurtado, A., Rey, T., Galan, H., Canete, F., Castro, B., Galindo, P., Munoza, C., El Hajra, I., Montiel, P., Abreu, I., Mesonero, F., … de Acosta, M. (2022). Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU).
Chicago
Rey, Ib, Cc Suarez, Am Luque, B Caballol, C Soutullo, A Bravo, A Castano, et al. 2022. “Safety of Inflammatory Bowel Disease Treatments in Patients with Solid Organ Transplantation (EITOS Study of GETECCU),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..2c5a86f812716796b49fb944f55a1af0&authtype=sso&custid=ns315887.